Chidinma Chima-Melton

Statistics

Publications

Citations

156

H-Index

Active since

2017

Affiliations

Baylor Medical Center at Garland(Current)

University of Nebraska Medical Center

Baylor University Medical Center

Certara (United States)

Gilead Sciences (United States)

Chidinma Chima-Melton is an author at Baylor Medical Center at Garland specializing in in-hospital mortality, pharmacotherapy, and infectious diseases.

ORCID

Publications per year

2017–2024

Publications

Remdesivir Reduced Mortality in Immunocompromised Patients Hospitalized for COVID-19 Across Variant Waves: Findings From Routine Clinical Practice

Essy Mozaffari, Aastha Chandak, Robert Gottlieb et al. · Clinical Infectious Diseases · 2023 · 58 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +11

Remdesivir Is Associated With Reduced Mortality in COVID-19 Patients Requiring Supplemental Oxygen Including Invasive Mechanical Ventilation Across SARS-CoV-2 Variants

Essy Mozaffari, Aastha Chandak, Robert Gottlieb et al. · Open Forum Infectious Diseases · 2023 · 32 citations · Full text

Medicine, Pharmacotherapy, Respiratory Therapy +16

Remdesivir is Associated with Reduced Mortality in Patients Hospitalized for COVID-19 Not Requiring Supplemental Oxygen

Essy Mozaffari, Aastha Chandak, Chidinma Chima-Melton et al. · Open Forum Infectious Diseases · 2024 · 18 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +13

Diagnosis of spinal epidural abscess: a case report and literature review

Chidinma Chima-Melton, Michelle Pearl, Marni Scheiner · Spinal Cord Series and Cases · 2017 · 17 citations · Full text

Medicine, Neurological Surgery, Neurosurgery +11

Remdesivir-Associated Survival Outcomes Among Immunocompromised Patients Hospitalized for COVID-19: Real-world Evidence From the Omicron-Dominant Era

Essy Mozaffari, Aastha Chandak, Robert Gottlieb et al. · Clinical Infectious Diseases · 2024 · 16 citations · Full text

Medicine, Infectious Diseases, Oncology +12

1–5 of 6